1. Kamada, Rui, Kudoh, Fuki, Ito, Shogo, Omichinski, James G, Sakaguchi, Kazuyasu. 2020. Metal-dependent Ser/Thr protein phosphatase PPM family: Evolution, structures, diseases and inhibitors. In Pharmacology & therapeutics, 215, 107622. doi:10.1016/j.pharmthera.2020.107622. https://pubmed.ncbi.nlm.nih.gov/32650009/
2. Zhu, Han, Qin, Hua, Li, De-Min, Liu, Jing, Zhao, Qiu. 2016. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells. In Oncology reports, 36, 2926-2934. doi:10.3892/or.2016.5065. https://pubmed.ncbi.nlm.nih.gov/27599670/
3. Dou, Dan, Smith, Erin M, Evans, Chantell S, Boecker, C Alexander, Holzbaur, Erika L F. 2023. Regulatory imbalance between LRRK2 kinase, PPM1H phosphatase, and ARF6 GTPase disrupts the axonal transport of autophagosomes. In Cell reports, 42, 112448. doi:10.1016/j.celrep.2023.112448. https://pubmed.ncbi.nlm.nih.gov/37133994/
4. Dou, Dan, Aiken, Jayne, Holzbaur, Erika L F. 2024. RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors. In The Journal of cell biology, 223, . doi:10.1083/jcb.202307092. https://pubmed.ncbi.nlm.nih.gov/38512027/
5. Shen, Tao, Sun, Chuang, Zhang, Zhengmao, Feng, Xin-Hua, Lin, Xia. 2014. Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H. In Cell research, 24, 727-41. doi:10.1038/cr.2014.48. https://pubmed.ncbi.nlm.nih.gov/24732009/
6. Xu, Xiaowen, Zhu, Li, Yang, Yun, Sui, Jinke, Cao, Fuao. 2019. Low tumour PPM1H indicates poor prognosis in colorectal cancer via activation of cancer-associated fibroblasts. In British journal of cancer, 120, 987-995. doi:10.1038/s41416-019-0450-5. https://pubmed.ncbi.nlm.nih.gov/30988394/
智鼠故事 
